Explore All Access
Check if your research matches the topics covered in Cancer Letters?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Cancer Letters : Impact Factor & More
eISSN: 1872-7980pISSN: 0304-3835
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Cancer Letters is a peer-reviewed medical journal established in 1975 that focuses on the rapid publication of original research on multidisciplinary aspects of cancer. The editor-in-chief is M. Schwab. Less
Cancer Letters Key Metrics
CiteScore 
16.1
Eigenfactor
0.01 - 0.05
H-Index
203
Impact Factor
5 - 10
Scite Index
0.93 5-Year SI
SJR
Q1Oncology
SNIP
1.69
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months41%
4 to 6 months52%
7 to 9 months5%
Above 9 months1%
Did you find this useful?
Topics Covered on Cancer Letters
Cancer
Carcinogenesis
Immune system
Extracellular vesicles
Hepatocellular carcinoma
Lung cancer
Radiation
Immunotherapy
Head and neck
Oxidative stress
Breast cancer
Autophagy
Epidermal growth factor receptor
Glycolysis
Gemcitabine
DNA damage
Tumor growth
Breast cancer cells
Fibronectin
Tumor progression
Cancer Letters Journal Specifications
| Overview | |
| Publisher | ELSEVIER IRELAND LTD |
| Language | English |
| Frequency | Fortnightly |
| General Details | |
| Language | English |
| Frequency | Fortnightly |
| Publication Start Year | 1975 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cancer Letters ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Letters
Clinical Challenges in Prostate Cancer Management: Metastatic Bone-tropism and The Role of Circulating Tumor Cells
- 1 Dec 2024
- Cancer Letters
Telaglenastat as an alternative to cisplatin as a radiosensitizer in the treatment of head and neck squamous cell carcinoma
- 1 Dec 2024
- Cancer Letters
Editorial Board
- 1 Dec 2024
- Cancer Letters
"Towards melanoma in situ vaccination with multiple ultra-narrow X-ray beams".
- 13 Nov 2024
- Cancer letters
Single-cell RNA-sequencing of human spleens reveals an IDO-1+ Tolerogenic Dendritic Cell subset in pancreatic cancer patients that is absent in normal individuals.
- 13 Nov 2024
- Cancer letters
The eIF3a translational control axis in the Wnt/β-catenin signaling pathway and colon tumorigenesis
- 1 Nov 2024
- Cancer Letters
Clinical Challenges in Prostate Cancer Management: Metastatic Bone-tropism and The Role of Circulating Tumor Cells
- 1 Dec 2024
- Cancer Letters
Telaglenastat as an alternative to cisplatin as a radiosensitizer in the treatment of head and neck squamous cell carcinoma
- 1 Dec 2024
- Cancer Letters
Editorial Board
- 1 Dec 2024
- Cancer Letters
"Towards melanoma in situ vaccination with multiple ultra-narrow X-ray beams".
- 13 Nov 2024
- Cancer letters
Single-cell RNA-sequencing of human spleens reveals an IDO-1+ Tolerogenic Dendritic Cell subset in pancreatic cancer patients that is absent in normal individuals.
- 13 Nov 2024
- Cancer letters
The eIF3a translational control axis in the Wnt/β-catenin signaling pathway and colon tumorigenesis
- 1 Nov 2024
- Cancer Letters
Compare Similar Journals with Cancer Letters
Select Journals to Compare with Cancer Letters
Total journals - 9
You can select up to 3 Journals at a time
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Cancers
Publisher: MDPI
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Oncotarget
Publisher: Impact Journals
International Journal of Molecular Sciences
Publisher: MDPI
Oncogene
Publisher: SPRINGERNATURE
Cell Death and Disease
Publisher: SPRINGERNATURE
Oncology Letters
Publisher: SPANDIDOS PUBL LTD
OncoTargets and Therapy
Publisher: DOVE MEDICAL PRESS LTD
0 Journals Selected to compare with
Cancer Letters
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Cancer Letters
How long has Cancer Letters been actively publishing? 
Cancer Letters has been in operation since 1975 till date.
What is the publishing frequency of Cancer Letters?
Cancer Letters published with a Fortnightly frequency.
How many articles did Cancer Letters publish last year?
In 2023, Cancer Letters publsihed 374 articles.
What is the eISSN & pISSN for Cancer Letters?
For Cancer Letters, eISSN is 1872-7980 and pISSN is 0304-3835.
What is Citescore for Cancer Letters?
Citescore for Cancer Letters is 16.1.
What is the H Index for Cancer Letters ?
H Index for Cancer Letters is 203.
What is SNIP score for Cancer Letters?
SNIP score for Cancer Letters is 1.69.
What is the SJR for Cancer Letters?
SJR for Cancer Letters is Q1.
Who is the publisher of Cancer Letters?
ELSEVIER IRELAND LTD is the publisher of Cancer Letters.
